Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Aarey Drugs & Pharmaceuticals Ltd

Pharmaceuticals & Biotechnology | Small Cap

Aarey Drugs & Pharmaceuticals Ltd Health Insights
Health Score : 5.73Health Score : 5.73

Aarey Drugs & Pharmaceuticals Ltd, operating within the Healthcare Services sector, demonstrates a mixed financial performance. The company exhibits strong solvency and profitability, indicating a solid financial foundation and efficient operations. However, growth metrics present a challenge, with declines in operating profit, EPS, asset growth, and net income. Liquidity is adequate, but there's room for improvement in managing short-term obligations. While the company shows good asset turnover and inventory management, collection periods for receivables are lengthy, impacting cash flow. Overall, Aarey Drugs & Pharmaceuticals showcases resilience but needs to address growth concerns to ensure long-term sustainability and competitiveness.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Aarey Drugs & Pharmaceuticals Ltd Health Insights
Health Score : 5.73Health Score : 5.73

Aarey Drugs & Pharmaceuticals Ltd, operating within the Healthcare Services sector, demonstrates a mixed financial performance. The company exhibits strong solvency and profitability, indicating a solid financial foundation and efficient operations. However, growth metrics present a challenge, with declines in operating profit, EPS, asset growth, and net income. Liquidity is adequate, but there's room for improvement in managing short-term obligations. While the company shows good asset turnover and inventory management, collection periods for receivables are lengthy, impacting cash flow. Overall, Aarey Drugs & Pharmaceuticals showcases resilience but needs to address growth concerns to ensure long-term sustainability and competitiveness.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

59.71

Highly Overvalued

Industry Median

28.62

Highly Overvalued
Highly Overvalued

Small Cap Median

27.17

Highly Overvalued

P/E RATIO

59.71

P/B RATIO

1.58

Undervalued

Industry Median

3.17

Undervalued
Undervalued

Small Cap Median

2.62

Undervalued

P/S RATIO

0.50

Highly Undervalued

Industry Median

3.42

Highly Undervalued
Highly Undervalued

Small Cap Median

2.55

Highly Undervalued

Others

Highly Undervalued

PEG RATIO

-5.64

Highly Undervalued
Overvalued

EV/EBITDA RATIO

18.26

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹83.6 as on Jun 20, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 4.00

The company's growth metrics present a mixed picture. While revenue growth is strong, there are declines in operating profit, earnings per share, asset growth, and net income. This suggests challenges in converting revenue growth into higher profits and efficient asset management. The company needs to address these areas to ensure sustainable growth.

ExcellentRevenue Growth RateExcellent
PoorOperating Profit Growth RatePoor
PoorEarnings Per Share (EPS) GrowthPoor
PoorAsset Growth RatePoor
PoorNet Income Growth RatePoor
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate41.67-15.01-5.4919.7-0.42
Operating Profit Growth Rate120-27.27-50-25133.33
Earnings Per Share (EPS) Growth-7.19-42.2512.08-14.97-1.41
Asset Growth Rate5.1518.784.12-3.962.06
Net Income Growth Rate0-42.8625-200
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 3.60

The company's financial ratios present challenges. Adjusted EPS and book value per share are at threshold, while dividend per share is low as the company does not distribute dividends. Cash EPS is at threshold. However, capital expenditures are relatively high, indicating ongoing investments in operational capabilities. The company needs to optimize these financial metrics to ensure long-term financial health.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
GoodCapital Expenditures (CapEx)Good
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)2.81.61.791.431.43
Cash Earnings Per Share (Cash EPS)3.62.42.52.142.5
Book Value Per Share45.246.847.549.2953.57
Dividend Per Share (DPS)00000
Capital Expenditures (CapEx)2.210.75.212.4
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 8.90

The company shows a good profitability profile. Gross profit margin is solid. Return on capital employed and return on equity are performing, indicating good returns on investments and shareholder equity. However, return on assets is low. Operating and net margins are strong, reflecting effective cost management and profitability.

GoodGross Profit MarginGood
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
PoorReturn on Assets (ROA)Poor
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin1.831.430.510.210.85
Return on Capital Employed (ROCE)106666
Return on Equity (ROE)6.193.423.762.92.67
Return on Assets (ROA)4.492.751.321.032.36
Operating Margin2.231.911.010.631.48
Net Margin1.420.951.260.840.85
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 6.33

The company's efficiency in asset utilization is a mix of strengths and weaknesses. Fixed asset and inventory turnover ratios are high, indicating efficient use of assets to generate revenue, and quick inventory processing. However, low receivables turnover and extended receivable days suggest slow collection of payments, which impacts cash flow and working capital management. Capital turnover is also low.

ExcellentFixed Asset Turnover RatioExcellent
ExcellentInventory Turnover RatioExcellent
PoorReceivables Turnover RatioPoor
ExcellentDays Sales in Inventory RatioExcellent
PoorReceivable DaysPoor
WeakCapital Turnover RatioWeak
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio35.2129.9330.4629.6218.15
Inventory Turnover Ratio30.1919.2112.2811.8210.76
Receivables Turnover Ratio3.312.572.122.993.59
Days Sales in Inventory Ratio12.091929.7230.8833.92
Receivable Days110.27142.02172.17122.07101.67
Capital Turnover Ratio4.243.452.913.393.13
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 4.40

The company's coverage ratios indicate mixed performance. The interest coverage ratio is at threshold, suggesting an acceptable ability to cover interest expenses with earnings. However, the equity dividend coverage ratio is low, as the company does not distribute dividends. This could affect investor perception.

AverageInterest Coverage RatioAverage
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio632.252.22
Equity Dividend Coverage Ratio
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company exhibits strong solvency, indicating a solid long-term financial position. All the solvency metrics, including debt ratio, debt to equity ratio, equity ratio and debt to asset ratio, reveal that the company has a low level of debt and a substantial equity base. This provides financial stability and reduces the risk of financial distress.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.030.040.020.010.01
Debt to Equity Ratio0.030.040.020.010.01
Equity Ratio0.970.960.980.990.99
Debt To Asset Ratio0.010.010.010.010
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 6.12

The company's liquidity position reveals strengths and weaknesses. The quick ratio indicates a good ability to meet short-term obligations with its most liquid assets. However, the cash ratio is very low, suggesting a reliance on other current assets besides cash. The current ratio is at average, while the operating cash flow ratio is weak, implying potential difficulties in generating cash from operations to cover current liabilities.

AverageCurrent RatioAverage
ExcellentQuick RatioExcellent
PoorCash RatioPoor
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.81.641.731.811.84
Quick Ratio1.691.461.521.511.55
Cash Ratio00.010.010.010.01
Operating Cash Flow Ratio0-0.01-0.020.070.07
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 11 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Par Drugs & Chemicals Ltd7.408.88Undervalued17.0010.6513.00
2Infinium Pharmachem Ltd6.4226.90Neutral22.006.4314.00
3Aarey Drugs & Pharmaceuticals Ltd5.7359.71Neutral7.001.404.00
4BPL Ltd5.46-31.11Neutral-4.82-3.00-8.55
5Zim Laboratories Ltd5.4141.96Neutral30.001.116.00
6Quest Laboratories Ltd5.2711.21Neutral18.009.1615.00
7Sotac Pharmaceuticals Ltd5.2721.26Neutral18.004.456.00
8Lyka Labs Ltd4.77-23.98Neutral-4.00-9.05-10.00
9Krebs Biochemicals & Industries Ltd4.16-5.27Highly Undervalued-4.00-12.49-4.00
10Nectar Lifescience Ltd3.83-2.67Neutral-59.00-2.95-293.00
Management Assessment Summary
OrangeBalanced Management

Aarey Drugs & Pharmaceuticals presents a mixed picture of management effectiveness. While there are positive aspects such as sales growth, concerns exist regarding profitability, returns on equity and promoter holding. The sales have grown, but profit margins and returns on equity are low. The decrease in promoter holding from 50.05% to 44.80% may reflect shifting management dynamics or strategic decisions. Overall, the company demonstrates strengths in revenue generation but needs to address profitability to improve overall management effectiveness.

Category Metric Value Assessment
PROS Sales Growth (TTM) 20% Revenue expansion
CONS Return on Equity (Last Year) 3% Low shareholder returns
Promoter Holding (Mar 2025) 44.80% Reduced promoter confidence
AverageFinancial Performance & GrowthAverage
PoorCapital Efficiency & ReturnsPoor
AverageShareholding & Ownership StructureAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

Aarey Drugs & Pharmaceuticals exhibits a moderate risk profile. Segment volatility is indicated by fluctuating quarterly sales growth. Exposure to interest rate risk is present due to borrowings. Overall, these factors suggest a need for cautious monitoring and strategic risk management.

AverageSegment performance volatilityAverage
AverageForeign exchange or interest rate exposureAverage
01.

Segment performance volatility

02.

Foreign exchange or interest rate exposure

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1081.93Bullish
  3. SMA 2081.21Bullish
  4. SMA 5079.21Bullish
  5. EMA 1082.01Bullish
  6. EMA 2081.26Bullish
  7. EMA 5080.01Bullish
  8. DEMA 1082.79Bearish
  9. DEMA 2082.50Bearish
  10. DEMA 5081.10Bullish
  11. TEMA 1082.89Bearish
  12. TEMA 2082.86Bearish
  13. TEMA 5082.34Bearish
  14. MACD0.95Bullish
  15. ADX22.07Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI53.99Neutral
  3. CCI166.72Overbought
  4. ROC 91.27Bullish
  5. ROC 141.40Bullish
  6. ROC 254.50Bullish
  7. Stoch K76.22Neutral
  8. Stoch D72.41Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper83.96Neutral
  3. BB Middle81.21Neutral
  4. BB Lower78.46Neutral
  5. ATR2.14High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI75.17Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1081.47Bullish
  3. SMA 2080.11Bullish
  4. SMA 5078.83Bullish
  5. EMA 1081.46Bullish
  6. EMA 2080.52Bullish
  7. EMA 5079.80Bullish
  8. DEMA 1082.56Bearish
  9. DEMA 2081.84Bullish
  10. DEMA 5079.53Bullish
  11. TEMA 1082.81Bearish
  12. TEMA 2082.60Bearish
  13. TEMA 5080.75Bullish
  14. MACD1.05Bullish
  15. ADX17.51Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI55.65Neutral
  3. CCI146.45Overbought
  4. ROC 91.71Bullish
  5. ROC 144.11Bullish
  6. ROC 258.71Bullish
  7. Stoch K75.69Neutral
  8. Stoch D75.88Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper83.70Neutral
  3. BB Middle80.11Neutral
  4. BB Lower76.52Neutral
  5. ATR2.49High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI66.82Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1080.09Bullish
  3. SMA 2079.41Bullish
  4. SMA 5080.59Bullish
  5. EMA 1080.29Bullish
  6. EMA 2079.77Bullish
  7. EMA 5080.22Bullish
  8. DEMA 1081.22Bullish
  9. DEMA 2079.95Bullish
  10. DEMA 5080.16Bullish
  11. TEMA 1081.70Bullish
  12. TEMA 2081.15Bullish
  13. TEMA 50N/AN/A
  14. MACD0.29Bullish
  15. ADX22.54Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI58.08Neutral
  3. CCI181.04Overbought
  4. ROC 93.87Bullish
  5. ROC 142.87Bullish
  6. ROC 259.37Bullish
  7. Stoch K75.22Neutral
  8. Stoch D76.11Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper82.25Neutral
  3. BB Middle79.41Neutral
  4. BB Lower76.57Neutral
  5. ATR3.27High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI82.06Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 1079.67Bullish
  3. SMA 2079.23Bullish
  4. SMA 5082.68Bullish
  5. SMA 10074.91Bullish
  6. SMA 20076.73Bullish
  7. EMA 1080.31Bullish
  8. EMA 2080.46Bullish
  9. EMA 5079.78Bullish
  10. EMA 10077.50Bullish
  11. EMA 20074.18Bullish
  12. DEMA 1080.96Bullish
  13. DEMA 2079.73Bullish
  14. DEMA 5082.43Bullish
  15. DEMA 10081.11Bullish
  16. DEMA 20080.61Bullish
  17. TEMA 1082.43Bullish
  18. TEMA 2079.15Bullish
  19. TEMA 5082.16Bullish
  20. TEMA 10082.16Bullish
  21. TEMA 20080.84Bullish
  22. MACD-0.38Bullish
  23. ADX23.50Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI57.42Neutral
  3. CCI163.58Overbought
  4. ROC 148.05Bullish
  5. ROC 25-8.43Bearish
  6. Stoch K87.20Overbought
  7. Stoch D80.63Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper83.71Neutral
  3. BB Middle79.23Neutral
  4. BB Lower74.76Neutral
  5. ATR4.35High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI78.80Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 2074.82Bullish
  3. SMA 5075.05Bullish
  4. EMA 2077.38Bullish
  5. EMA 5072.80Bullish
  6. DEMA 2080.71Bearish
  7. DEMA 5080.03Bearish
  8. TEMA 2081.87Bearish
  9. TEMA 5080.53Bearish
  10. MACD2.69Bullish
  11. ADX19.39Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI52.05Neutral
  3. CCI22.21Neutral
  4. ROC 148.65Bullish
  5. ROC 2513.63Bullish
  6. Stoch K60.37Neutral
  7. Stoch D65.88Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper96.34Neutral
  3. BB Middle74.82Neutral
  4. BB Lower53.30Neutral
  5. ATR8.95Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI66.50Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 671.97Bullish
  3. SMA 1274.26Bullish
  4. SMA 2463.94Bullish
  5. EMA 675.22Bullish
  6. EMA 1271.69Bullish
  7. EMA 2465.18Bullish
  8. DEMA 678.02Bearish
  9. DEMA 1278.36Bearish
  10. DEMA 2476.37Bullish
  11. TEMA 678.13Bearish
  12. TEMA 1278.53Bearish
  13. TEMA 24N/AN/A
  14. MACD12.46Bullish
  15. ADX22.48Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI54.98Neutral
  3. CCI154.78Overbought
  4. ROC 2549.12Bullish
  5. ROC 5088.15Bullish
  6. Stoch K69.22Neutral
  7. Stoch D62.01Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper97.52Neutral
  3. BB Middle64.85Neutral
  4. BB Lower32.18Neutral
  5. ATR18.20Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI62.12Neutral